Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- Engineered Dendritic Cells Harness Tumor EVs to Boost Cancer Immunotherapy
- Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
- Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
- The 98% mystery: Scientists just cracked the code on “junk DNA” linked to Alzheimer’s
- New method preserves iPS cells for regenerative medicine
- MIT Scientists Have Discovered a Way To Rejuvenate the Immune System

